Expression and export technology of proteins as immunofusins
CA 2199830 C · Owner: Sudo, Yukio · Inventors: Lo, Kin-Ming; Gillies, Stephen D.; Sudo, Yukio
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Disclosed are DNAs produced by recombinant techniques for inducing the expression and subsequent secretion of a target protein. The DNAs encode in , their 5' to 3' direction, a secretion cassette including a signal sequence , and an immunoglobulin Fc region and a target protein. The DNAs can be transfected into a host cell for the expression production and subsequent , secretion of the target protein as a fusion protein. The secreted protein can be collected from the extracellular space and further purified as desired. , The secreted fusion protein additionally can be proteolytically cleaved to release the target protein from the secretion cassette.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed September 14, 1995 and granted May 6, 2003. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended September 14, 2015.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by September 14, 2017.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.